- Cancer and Blood Diseases (10)
- Diabetes and Endocrinology (5)
- Fetal Care (3)
- Gastroenterology, Hepatology and Nutrition (10)
- Heart (21)
- Mental and Behavioral Health (10)
- Nephrology (4)
- Neurology and Neurosurgery (10)
- Orthopaedics (8)
- Perinatal (3)
- Pulmonary Medicine (8)
- Urology (5)
Search by Keyword
Results (95)
$1.48M State Grant Boosts ENGRAFT Learning Network
Ohio Gov. Mike DeWine stopped by Cincinnati Children’s on Dec. 5 to announce a major boost for pediatric cancer research—a $1.48 million grant to power the ENGRAFT learning network. This collaborative effort brings together experts, families, and partners to transform outcomes for kids needing stem cell transplants, as part of a $5 million statewide investment in fighting childhood cancer.
3D Imaging Guidance to Reverse Growth Plate Injury
Discover how Cincinnati Children’s uses 3D imaging to improve precision and outcomes in pediatric physeal bar excision surgery.
A Bold Investment to Make the Future of Medicine Happen
The new Applied Gene and Cell Therapy Center will expand capacity for manufacturing viral vectors and cell-based products under Current Good Manufacturing Practice conditions, supporting complex trials in oncology, hematology and rare genetic disorders, with capabilities for large-scale bioreactor production and post-approval therapy manufacturing.
Addressing Scholastic and Mental Health Needs in Patients with Cystic Fibrosis
Discover how Cincinnati Children’s CF WELL program is transforming care for children with cystic fibrosis—addressing educational and mental health needs alongside clinical advances.
Advanced Imaging Identifies Seizure Onset Beyond the Temporal Lobe
User-defined virtual sensor beamforming pinpoints seizure onset zones beyond the temporal lobe, providing a solution for locating epilepsy sources other methods miss.
Advanced Kidney Organoids Produce Early-Stage Plumbing Needed for Removing Waste
Researchers have achieved a breakthrough in kidney organoid development by creating early-stage plumbing that connects nephrons to waste-carrying tubules.
Advancements Bring New Hope for Sickle Cell Disease
A Phase II clinical trial conducted in Ghana suggests that hydroxyurea — already a treatment offered for the most common form of sickle cell disease — also shows benefits for those with the hemoglobin SC (HbSC) variant of the condition.
Advancements Bring New Hope for Sickle Cell Disease
Cincinnati Children’s researchers present new findings on sickle cell disease, highlighting underused therapies and promising advances in treatment options.
Advancing Catheter Ablation for CHD Patients
Cincinnati Children’s is advancing catheter ablation techniques to treat arrhythmias in patients with congenital heart disease.
Advancing Gene Therapy in Pediatric Hematology and Oncology
Cincinnati Children’s advances telomere elongation therapy for rare marrow failure syndromes, supported by its Applied Gene and Cell Therapy Center—a new hub designed to speed gene and cell therapy breakthroughs from research to patient care.
3333 Burnet Avenue, Cincinnati, Ohio 45229-3026
© 1999-2025 Cincinnati Children's Hospital Medical Center. All rights reserved.
